Ffp2 Coronavirus
ffp2 coronavirus, Vice President Mike Pence weighs in on U.S. preparation for a potential outbreak, Democrats' politicization of the disease in an exclusive interview on 'Hannity.' We applaud President Trump for putting Vice President Pence in charge of the U.S. government’s response to the novel coronavirus pandemic. The Bipartisan Commission on Biodefense we co-chair made this very recommendation four years ago. Too bad it took a crisis to get it done, but that’s Washington. Here’s what our National Blueprint for Biodefense said about this in 2015:
ffp2 coronavirus - “The nation lacks a single leader to control, prioritize, coordinate, and hold agencies accountable for working toward common national biodefense. This weakness precludes sufficient defense against biological threats. A leader must, therefore, take charge of our nation’s response to biological crises, as well as day-to-day activities in the absence of such crises. Leadership of biodefense should be institutionalized at the White House with the vice president. This office alone can be imbued with the authority of the president to coordinate agencies, budgets, and strategies across the government in a way that no other position can.”
ffp2 coronavirus, FDA ANNOUNCES CORONAVIRUS-RELATED DRUG SHORTAGE IN US While it appears Vice President Pence’s oversight responsibilities are limited to the novel coronavirus response, we hope the president ultimately puts the vice president in charge of the entire biodefense enterprise to ensure that the government is working optimally to defend against naturally occurring diseases like novel coronavirus, accidents, biological terrorism and the threat of biological warfare from other nation-states.
ffp2 coronavirus - Unfortunately, the Department of State’s own assessment shows that other countries are developing biological weapons, terrorist organizations want to engage in bioterrorism and that our government does not afford the biological threat the same level of attention as it does other threats. There is no permanent, centralized leader for biodefense. The White House deserves credit for issuing a National Biodefense Strategy in 2018 – another of our initial 2015 recommendations – however, as the Government Accountability Office confirmed recently, it still needs to be fully implemented. There is no doubt this has held our coronavirus response back. We also need an all-inclusive dedicated biodefense budget, as the sudden request for billions in emergency appropriations made quite apparent this week.
ffp2 coronavirus - As a nation, we are trying to get ahead of the virus, however, it is too late to prevent it. Now we must do what we can to contain it until we can develop a vaccine for it or warmer weather slows its spread. CLICK HERE TO SIGN UP FOR OUR OPINION NEWSLETTER Moving forward, we urge the vice president to establish a stratified biodefense hospital system with hospitals at different levels that can treat patients with any novel or unusual disease (as opposed to funding handfuls of different hospitals to treat each new disease that comes along) – just like we do with different levels of trauma centers. It might be appropriate for a handful of high-level hospitals to treat a handful of patients with novel coronavirus, but that will no longer be feasible if thousands of people need care and our own country imposes travel restrictions.